Hydrochloric Acid → 2-chloromethyl-N-(4-methoxy-7-morpholin-4-yl-benzooxazol-2-yl)-isonicotinamide
Reaction equation
[Cl:1][CH2:2][C:3]1[CH:4]=[C:5]([CH:9]=[CH:10][N:11]=1)[C:6]([OH:8])=O.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(C(C)C)C(C)C)C.[CH3:45][O:46][C:47]1[C:52]2[N:53]=[C:54]([NH2:56])[O:55][C:51]=2[C:50]([N:57]2[CH2:62][CH2:61][O:60][CH2:59][CH2:58]2)=[CH:49][CH:48]=1.Cl>C1COCC1.O1CCOCC1.CN(C=O)C.O>[Cl:1][CH2:2][C:3]1[CH:4]=[C:5]([CH:9]=[CH:10][N:11]=1)[C:6]([NH:56][C:54]1[O:55][C:51]2[C:50]([N:57]3[CH2:62][CH2:61][O:60][CH2:59][CH2:58]3)=[CH:49][CH:48]=[C:47]([O:46][CH3:45])[C:52]=2[N:53]=1)=[O:8]Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 4
Procedure
To a stirred solution of 72 mg (0.42 mmol) 2-choromethyl-isonicotinic acid in 5 ml THF were added 183 mg (0.48 mmol) HATU and 0.08 ml (0.48 mmol) N-ethyldiisopropylamine and stirring continued at room temperature for 5 h. A solution of 80 mg (0.32 mmol) 4-methoxy-7-morpholin-4-yl-benzooxazol-2-yl-amine in 5 ml dioxane and 1 ml DMF was then added and stirring continued at 40° C. for 48 h. The reaction mixture was then poured into 50 ml water, acidified with 1 M aq. hydrochloric acid, and extracted three times with ethyl acetate. The combined organic phases were dried over sodium sulfate and concentrated in vacuo. Flash chromatography (3/97 methanol/dichloromethane, then 10/90 methanol/dichloromethane) followed by trituration in ether afforded 8 mg (6%) 2-chloromethyl-N-(4-methoxy-7-morpholin-4-yl-benzooxazol-2-yl)-isonicotinamide as an off-white crystalline solid. ES-MS m/e (%): 405 (M{37Cl}+H+, 35), 403 (M{35Cl}+H+, 100).
Workup
- stirringstirring
- waitcontinued at 40° C. for 48 h
- extractionextracted three times with ethyl acetate
- dry with materialThe combined organic phases were dried over sodium sulfate
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-7dc4db4231d7439a91b8206957928123
- Source dataset
- uspto-grants-2006_01
- Patent number
- US06992083B2
Reaction notes
Loading…